Companies: 10,795·Total market cap: $144.5T
Foghorn Therapeutics Inc.

Foghorn Therapeutics Inc.

FHTXNASDAQHealthcare● Active
$3.71
$-0.02(-0.54%)
Market Cap$217828569
P/E Ratio—
52W High$6.95
52W Low$3.27
Overview
Stock ranking:Biotechnology·Healthcare·View All Market Cap Rankings →

Foghorn Therapeutics Inc. (FHTX) Stock Overview

Key statistics and deep links to earnings, valuation, revenue, dividends, and more.

FMP · FHTX · as of Jun 9, 2026

Key Statistics

EPS (TTM)$-1.17fhtx eps ttm · fhtx earnings per shareEarnings history
PE Ratio (TTM)—fhtx pe ratio ttm · fhtx price to earningsPE Ratio deep dive
Revenue (TTM)$28.2Mfhtx revenue ttm · fhtx annual revenueFull revenue history
Dividend YieldNo Dividenddoes fhtx pay dividends · fhtx dividend yieldDividend history
Shares Outstanding63.0Mfhtx shares outstanding · fhtx floatShares outstanding history
Next EarningsAug 4, 2026Est.fhtx earnings date · fhtx next earningsEarnings history

Explore Foghorn Therapeutics Inc. Data

fhtx stock data · financials
Market Cap$217.8Mfhtx market cap · fhtx valuation
Analyst Forecast$12 · Buy
DividendsNo Dividenddoes foghorn therapeutics inc. pay dividends · fhtx dividend yield
Revenue$30.9M+36.75%foghorn therapeutics inc. annual revenue · fhtx revenue
EarningsEPS $-1.18+25.32%fhtx earnings · fhtx eps
PE Ratio—fhtx pe ratio · fhtx price to earnings

Financial Snapshot

Full Financials
FY 2025Revenue$30.9M▲ +36.75% YoY
202320242025
foghorn therapeutics inc. revenue · fhtx revenue 2025
FY 2025Net Income-$74.3M▲ +14.24% YoY
202320242025
foghorn therapeutics inc. net income · fhtx profit 2025
FY 2025EPS$-1.18▲ +25.32% YoY
202320242025
fhtx eps · foghorn therapeutics inc. earnings per share 2025
TTM:Revenue: $28.2MNet Income: -$75.3MEPS: $-1.17View income statement →

Analyst Ratings & Price Target

Full Forecast
SellBuy
Buy9 analystsis fhtx a buy · fhtx analyst rating
Strong Buy
0
Buy
8
Hold
1
Sell
0
Strong Sell
0
12-Month Price Target
$11.00Low
$3.71Current
$11.50Avg Target209.97% upside
$12.00High
fhtx price target · fhtx 12 month forecast

Total: 9 · Buy rate: 88.9%

The FHTX analyst consensus is Buy, based on ratings from 9 Wall Street analysts over the past 3 months. The average 12-month price target is $11.50, representing +209.97% upside from the current price of $3.71.

Stock Performance

Full History
1D-0.54%
1W+2.49%
1M-16.44%
3M-35.81%
YTD-31.30%
1Y-19.17%
5Y-65.93%

About Foghorn Therapeutics Inc.

CEOAdrian H. Gottschalk
IPO DateOct 23, 2020
Employees112
CountryUS
Websitefoghorntx.com

Foghorn Therapeutics Inc. is a clinical-stage biopharmaceutical company dedicated to discovering and developing medicines. Their focus is on addressing genetically determined vulnerabilities within th…

BiotechnologyHealthcareNASDAQUS

what is foghorn therapeutics inc. · fhtx stock overview · foghorn therapeutics inc. company profile · who is foghorn therapeutics inc. ceo · fhtx NASDAQ · foghorn therapeutics inc. headquarters · foghorn therapeutics inc. business segments

About Stock Overview & Key Data

Foghorn Therapeutics Inc. (FHTX) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Oct 23, 2020. As of the latest trading session, FHTX stock price is $3.71, with a market capitalization of $217.8M. The stock has returned -19.17% over the past 12 months and -31.30% year-to-date.

According to 9 Wall Street analysts, the consensus rating for Foghorn Therapeutics Inc. stock is Buy, with an average 12-month price target of $11.50. In fiscal year 2025, Foghorn Therapeutics Inc. reported revenue of $30.9M and net income of -$74.3M. For detailed data — including Foghorn Therapeutics Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.

Frequently Asked Questions

As of the latest trading session, Foghorn Therapeutics Inc. (FHTX) stock price is $3.71. The stock is traded on NASDAQ under the ticker symbol FHTX. The 52-week range is $3.27 – $6.95.

FHTX stock priceFHTX quote todaylive ticker
Data provided by Financial Modeling PrepLast updated: Jun 9, 2026Not investment advice